The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 18, 2016
Filed:
Feb. 19, 2016
Applicant:
Plexxikon Inc., Berkeley, CA (US);
Inventors:
Guoxian Wu, Foster City, CA (US);
Jiazhong Zhang, Foster City, CA (US);
Yong-Liang Zhu, Fremont, CA (US);
Chao Zhang, Moraga, CA (US);
Prabha N. Ibrahim, Mountain View, CA (US);
Songyuan Shi, Fremont, CA (US);
Wayne Spevak, Berkeley, CA (US);
Dean R. Artis, Kensington, CA (US);
James Tsai, Vallejo, CA (US);
Assignee:
Plexxikon Inc., Berkeley, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 213/72 (2006.01); C07D 285/12 (2006.01); C07D 261/04 (2006.01); C07D 231/00 (2006.01); A61K 31/44 (2006.01); A61K 31/41 (2006.01); A61K 31/42 (2006.01); A61K 31/415 (2006.01); C07D 471/04 (2006.01); C07D 213/75 (2006.01); C07D 213/82 (2006.01); C07D 215/12 (2006.01); C07D 215/20 (2006.01); C07D 215/38 (2006.01); C07D 239/48 (2006.01); C07D 263/48 (2006.01); C07D 417/12 (2006.01); A61K 31/437 (2006.01); A61K 31/444 (2006.01); A61K 31/47 (2006.01); A61K 31/5377 (2006.01); A61K 31/549 (2006.01); A61K 45/06 (2006.01); C07D 215/14 (2006.01); C07D 261/14 (2006.01); C07D 285/16 (2006.01); A61K 31/4439 (2006.01); A61K 31/505 (2006.01); C07D 213/76 (2006.01); C07D 239/49 (2006.01); A61K 31/506 (2006.01); C07D 417/04 (2006.01); C07D 213/74 (2006.01); C07D 231/40 (2006.01); C07D 285/135 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/42 (2013.01); A61K 31/437 (2013.01); A61K 31/44 (2013.01); A61K 31/444 (2013.01); A61K 31/4439 (2013.01); A61K 31/47 (2013.01); A61K 31/505 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 31/549 (2013.01); A61K 45/06 (2013.01); C07D 213/74 (2013.01); C07D 213/75 (2013.01); C07D 213/76 (2013.01); C07D 213/82 (2013.01); C07D 215/12 (2013.01); C07D 215/14 (2013.01); C07D 215/20 (2013.01); C07D 215/38 (2013.01); C07D 231/40 (2013.01); C07D 239/48 (2013.01); C07D 239/49 (2013.01); C07D 261/14 (2013.01); C07D 263/48 (2013.01); C07D 285/135 (2013.01); C07D 285/16 (2013.01); C07D 401/12 (2013.01); C07D 405/12 (2013.01); C07D 409/12 (2013.01); C07D 417/04 (2013.01); C07D 417/12 (2013.01);
Abstract
Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.